Data / Form D filings / Access Vascular, Inc.
Access Vascular, Inc.: Form D filings
Access Vascular, Inc., a biotechnology company in Bedford, MA, filed 6 Form D notices with the SEC between 2017 and 2023. The latest, on October 30, 2023, reports $20.6 million sold of a $31.6 million offering to 19 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 175 MIDDLESEX TURNPIKE, SUITE 1A, Bedford, MA, 01730
- Phone
- (781) 538-6594
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1714846
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 30, 2023 | New notice | $31,596,440 | $20,646,440 | $10,950,000 | 19 | Oct 13, 2023 | sec.gov |
| Oct 19, 2022 | New notice | $10,000,000 | $0 | $10,000,000 | 2 | Oct 6, 2022 | sec.gov |
| Mar 9, 2021 | New notice | $19,895,191 | $19,895,191 | 14 | Feb 23, 2021 | sec.gov | |
| Sep 9, 2019 | New notice | $7,257,884 | $5,552,706 | $1,705,178 | 15 | Aug 23, 2019 | sec.gov |
| May 16, 2018 | New notice | $4,005,880 | $1,922,000 | $2,083,880 | 7 | May 4, 2018 | sec.gov |
| Aug 16, 2017 | New notice | $3,774,000 | $3,774,000 | 25 | Aug 7, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| JJ Pelligrino | Director | |
| Amine R Bentaleb | Director | |
| James Biggins | Executive Officer | |
| Luc R Marengere | Director | |
| Michael R Jaff | Director | |
| Marc R Riviere | Director | |
| Brent Sabin | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Oct 30, 2023 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Access Vascular, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.